1 – 4 of 4
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
- Treatment costs for advanced prostate cancer using luteinizing hormone-releasing hormone agonists: a solid biodegradable leuprorelin implant versus other formulations
- 2013
- New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists
-
Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia
Bezard, Erwan ; Munoz, Ana ; Tronci, Elisabetta ; Pioli, Elsa Y. ; Li, Qin ; Porras, Gregory ; Björklund, Anders LU
and Carta, Manolo
(2013)
In Neuroscience Research
77(4).
p.242-246
Mark
- 2009
- Novel and potent small-molecule urotensin II receptor agonists